Process for enhancing the viable counts of lactic acid bacteria and useful composition thereof
US 10,293,008; AU2015308650; EA034017; EP3185877; HK1233174; IDP000066793; JP6630723; KR10-2089566; MX376004; MY-174855-A; SG11201700006U; ZL201580042813.X; NZ748360; US 10,323,227; US 9,717,766; PH1-2017-500059
Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856
EA037312; EP3240553; JP6629875; KR10-2157043; MY-182658-A; US 9,579,352;
ZL 201680008035.7; PH1-2017-501327 B1; MX384468; NZ732234; HK1240122
Bacillus coagulans MTCC 5856 for the management of major depressive disorder
US 10,166,261; AU2016413572; CA3023818; ZA2019/00501; EP3478304; EA038255; JP6908633; NZ748553
Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856
US 10,260,112; CA2999517; EP3356545; MY-185340-A; IDP000074645; JP6938479
Composition for management of Helicobacter pylori infection
US 10,792,295; JP6839329; AU2018281141, KR 10-2403453
Beverage compositions containing Bacillus coagulans MTCC 5856
US 10,609,935; US 11,122,814; JP7076148
Compositions and methods for reducing flatulence
US 10,806,760; AU2018282018; JP6987888
Modulation of immune function by Bacillus coagulans
ZA2020/07348; US 11,298,381
Anti-pollution compositions containing Bacillus coagulans
RU2745755; KR10-2376076
Alcoholic beverage composition containing Bacillus coagulans
AU2018337853; US 11,332,702
Hypolipidemic effects of Bacillus coagulans
US 11,213,553
Stable probiotic composition for the management of lactose intolerance
US 11,202,810
Stable probiotic compositions containing Bacillus coagulans MTCC 5856 and method of detection thereof
US 10,668,115